Geneva, April 20 -- International Clinical Trials Registry received information related to the study (ChiCTR2600122097) titled 'Forecasting IVUS-Identified High-Risk Coronary Plaques Utilizing a Deep Learning Model that Integrates Microvascular (Retinal) and Macrovascular (Angiographic) Imaging Characteristics' on April 9.
Study Type: Diagnostic test
Study Design:
Diagnostic test for accuracy
Primary Sponsor: The 7th People's Hospital of Zhengzhou
Condition:
Coronary atherosclerotic heart disease
Intervention:
Gold Standard:Definition of Vulnerable Plaque by IVUS: A plaque is defined as high-risk/vulnerable if it meets at least one of the following criteria:
Plaque burden > 70%.
Minimum lumen area (MLA) < 4.0 mm^2.
Recruitment St...